MedTrace Logo

fMRI Tracking taVNS in ASD

NCT06698328 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-02-05

No results posted yet for this study

Summary

The purpose of this study is to explore whether a non-invasive form of ear stimulation called transcutaneous auricular vagus nerve stimulation (taVNS) can manage symptoms in patients with autism spectrum disorder (ASD). Additionally, this study also uses magnetic resonance imaging (MRI) to capture images of participants' brains and apply an image processing method called INSCAPE to track brain state changes during taVNS treatment in ASD. Investigators will recruit up to 16 participants with ASD.

Conditions

  • Autistic Spectrum Disorders

Interventions

DEVICE

Transauricular Vagus Nerve Stimulation

Mild non-invasive electrical stimulation to the vagus nerve using electrodes or "stickers" that adhere to the ear and the surrounding area.

DEVICE

Sham Stimulation

Sham non-invasive electrical stimulation using electrodes or "stickers" that adhere to the ear and the surrounding area.

Sponsors & Collaborators

  • MUSC COBRE in Neurodevelopment and its Disorders (CNDD) Pilot Projects Program (PPP)

    collaborator UNKNOWN

  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Xiaolong Peng · Medical University of South Carolina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-10
Primary Completion
2026-02-02
Completion
2026-02-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06698328 on ClinicalTrials.gov